Bilypsa Tablet

Bilypsa tablet is an antidiabetic drug containing the active ingredient Saroglitazar. It belongs to the medication class of dual peroxisome proliferator-activated receptor (PPAR) agonists. It is indicated for the treatment of diabetic dyslipidemia (abnormal lipid levels in blood) and hypertriglyceridemia (elevated triglyceride levels in blood) in patients with type 2 diabetes mellitus inadequately controlled by statin therapy. Bilypsa tablet should not be used if you have an allergy to Saroglitazar or any other ingredient in the formulation. Prior to commencing treatment, inform your doctor if you have hepatic or renal impairment or a previous history of muscle disorders. This medicine has not been evaluated in patients with severe heart failure; caution is advised in those with cardiac disease. Although weight gain and oedema are uncommon, rapid weight gain warrants monitoring for signs of swelling and heart failure. Safety and efficacy of Bilypsa tablet have not been established in the paediatric population. Before initiating treatment, inform your doctor if you are pregnant, suspect you may be pregnant, are planning pregnancy, or are breastfeeding.

Treats diabetic dyslipidemia (an abnormal amount of lipids in the blood) Hypertriglyceridemia (high level of triglycerides in the blood)

Bilypsa tablet works by managing high cholesterol and triglycerides, along with blood sugar levels in type 2 diabetes. Its unique mechanism reduces the synthesis and secretion of triglycerides, improving insulin sensitivity for better utilization and lowering blood sugar levels.

Take the Bilypsa tablet as your physician advises. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Common Gastritis (stomach inflammation) Nausea Vomiting Asthenia (weakness) Chest discomfort Dizziness Fever Weakness

Patients with liver, heart, and kidney conditions should take Bilypsa tablet cautiously and should inform the doctor about all the underlying medical conditions. Do not stop the medicine until your doctor advises. Do not double-dose the medicine to make up for a forgotten dose. Notify your doctor if you experience any serious side effects. Your medical professional will inform you if you need any dose adjustments. Contact your doctor for more information.